Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thymus Dosimetric and Morphologic Predictors of Radiation-Induced Lymphopenia in Stage III NSCLC

NCT07564089 is registered in ClinicalTrials.gov with You Peimeng as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07564089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thymus Dosimetric and Morphologic Predictors of Radiation-Induced Lymphopenia in Stage III NSCLC
Lead sponsor
You Peimeng
Phase
Observational
Overall status
Active, not recruiting
Start date
April 10, 2026
Completion date
February 28, 2028
Enrollment
450 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

number of lymphocytes, radiation-induced lymphopenia, thymus dosimetric